Company Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally.
It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy.
The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits.
It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E.
coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups.
In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station.
It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers.
IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
| Country | United States |
| Founded | 1983 |
| IPO Date | Jun 21, 1991 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 11,000 |
| CEO | Jonathan Mazelsky |
Contact Details
Address: One IDEXX Drive Westbrook, Maine 04092 United States | |
| Phone | 207 556 0300 |
| Website | idexx.com |
Stock Details
| Ticker Symbol | IDXX |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000874716 |
| CUSIP Number | 45168D104 |
| ISIN Number | US45168D1046 |
| Employer ID | 01-0393723 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Jonathan J. Mazelsky | President, Chief Executive Officer and Director |
| Bob Asmann | Senior Vice President of Global Operations |
| Amit Gupta | Senior Vice President, Chief Digital and Information Officer |
| Sharon E. Underberg J.D. | Executive Vice President, General Counsel, and Corporate Secretary |
| Julie Godon | Senior Vice President and Global Marketing Officer |
| Michael P. Johnson | Executive Vice President and Chief Human Resources Officer |
| George J. Fennell | Executive Vice President of Global CAG Commercial |
| Jeffery D. Chadbourne | Senior Vice President of Commercial Finance and Sales Operations |
| Michael G. Erickson Ph.D. | Executive Vice President and GM of Point of Care Diagnostics and Telemedicine |
| Murthy Yerramilli | Senior Vice President of Assay and Instrument Research and Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 27, 2026 | ARS | Filing |
| Mar 27, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 27, 2026 | DEF 14A | Other definitive proxy statements |
| Mar 27, 2026 | SCHEDULE 13G/A | Filing |
| Mar 26, 2026 | 8-K | Current Report |
| Mar 13, 2026 | PRE 14A | Other preliminary proxy statements |
| Mar 3, 2026 | 144 | Filing |
| Feb 26, 2026 | 144 | Filing |
| Feb 25, 2026 | 144 | Filing |
| Feb 20, 2026 | 10-K | Annual Report |